| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | NEUTRAL | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.42▲ | 4.37▲ | 4.32▲ | 4.60▼ | 3.98▲ |
| MA10 | 4.44▲ | 4.33▲ | 4.41▲ | 4.55▼ | 4.09▲ |
| MA20 | 4.35▲ | 4.42▲ | 4.51▼ | 4.13▲ | 5.75▼ |
| MA50 | 4.41▲ | 4.61▼ | 4.51▼ | 4.29▲ | 12.39▼ |
| MA100 | 4.50▼ | 4.53▼ | 4.21▲ | 6.14▼ | N/A |
| MA200 | 4.61▼ | 4.15▲ | 4.02▲ | 11.16▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.014▲ | 0.017▲ | -0.025▼ | 0.100▲ | 0.224▲ |
| RSI | 55.934▲ | 49.584▼ | 47.221▼ | 51.479▲ | 31.796▼ |
| STOCH | 62.777 | 53.158 | 21.554 | 75.839 | 21.172 |
| WILL %R | -18.868▲ | -46.512 | -56.604 | -34.940 | -76.749▼ |
| CCI | 42.313 | 80.326 | -12.337 | 28.416 | -25.782 |
|
Thursday, May 15, 2025 01:05 PM
SAN DIEGO--(BUSINESS WIRE)-- Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the ...
|
|
Thursday, May 15, 2025 09:05 AM
Contineum Therapeutics (Nasdaq: CTNM) is a clinical-stage biopharmaceutical company pioneering novel, oral small molecule therapies for NI&I indications with significant unmet need. Contineum is ...
|
|
Wednesday, May 14, 2025 01:05 PM
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 4.52 | 4.62 | 4.182 | 4.43 | 145,200 |
| 12/06/25 | 4.62 | 4.8791 | 4.44 | 4.63 | 114,838 |
| 11/06/25 | 4.97 | 4.97 | 4.46 | 4.57 | 117,553 |
| 10/06/25 | 4.56 | 5.01 | 4.56 | 4.89 | 91,985 |
| 09/06/25 | 4.80 | 4.80 | 4.43 | 4.48 | 56,800 |
| 06/06/25 | 4.16 | 4.765 | 3.98 | 4.75 | 67,700 |
| 05/06/25 | 4.42 | 4.42 | 4.11 | 4.15 | 50,000 |
| 04/06/25 | 4.75 | 4.76 | 4.3862 | 4.41 | 86,669 |
| 03/06/25 | 4.42 | 4.76 | 4.16 | 4.74 | 567,022 |
| 02/06/25 | 3.825 | 4.70 | 3.75 | 4.43 | 154,936 |
|
|
||||
|
|
||||
|
|